The widespread utilization of chest CT scans has increased the importance of the proper evaluation of incidentally found lung nodules. The primary goal in the evaluation of these nodules is to ...

But now there’s rising optimism among leading infectious disease experts after the latest groundbreaking clinical trial results for a drug called lenacapavir which have shown it to be capable of ...

In a Phase 3 clinical trial, 99.9% of participants who took a twice-a-year injection of lenacapavir for HIV prevention did not acquire an infection, according to data from drugmaker Gilead Sciences.

Among 2,180 people receiving the injection, lenacapavir, there were only two cases of HIV, Gilead said in a release. Lenacapavir also proved superior in the trial to Gilead’s once-daily Truvada ...

Lung nodules are small growths in your lungs, less than 30 millimeters in diameter. Many nodules aren’t cancerous, but the risk becomes higher with increased size. A lung nodule is an irregular ...

In newly released data, lenacapavir, administered via a twice-yearly injection, has shown remarkable effectiveness at eliminating HIV transmission... Can we eliminate the HIV epidemic? It’s a ...

Gilead Sciences’ capsid inhibitor lenacapavir has the most competitive potential in long-acting combination regimens in HIV, including with Merck’s islatravir, experts said. Early lenacapavir ...

But now there’s rising optimism among leading infectious disease experts after the latest groundbreaking clinical trial results for a drug called lenacapavir which have shown it to be capable of ...

But now there’s rising optimism among leading infectious disease experts after the latest groundbreaking clinical trial results for a drug called lenacapavir which have shown it to be capable of ...